Secondly, our models have highlighted that low and high-grade gliomas are characterised by a switch in the activity of two different sets of Rho GTPases, among which RND3 is a key regulator of tumour proliferation, migration, apoptosis and invasion. The gene discussed is RND3; the disease is central nervous system cancer.